Answers are grounded in this paper and cite their sources.
Serum cytokine levels are potential disease progression markers in ALK + NSCLC. Further validation in a larger and prospective cohort is necessary to determine whether the addition of cytokine evaluation could improve current tumour monitoring modalities in the clinical setting.
No takes yet. Share an insight, caveat, or question.
Angeles et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: